Parkinson’s disease is the
second most prevalent neurological
disease after Alzheimer’s. Primarily, old age males are more
affected than females. The aggregates of oligomeric forms of α-synuclein
cause the loss of dopaminergic neurons in the substantia nigra pars
compacta. Further, it leads to dopamine shortage in the striatum region.
According to recent preclinical studies, environmental factors like
pesticides, food supplements, pathogens, etc. enter the body through
the mouth or nose and ultimately reach the gut. Further, these factors
get accumulated in enteric nervous system which leads to misfolding
of α-synuclein gene, and aggregation of this gene results in
Lewy pathology in the gut and reaches to the brain through the vagus
nerve. This evidence showed a strong bidirectional connection between
the gut and the brain, which leads to gastrointestinal problems in
Parkinson patients. Moreover, several studies reveal that patients
with Parkinson experience more gastrointestinal issues in the early
stages of the disease, such as constipation, increased motility, gut
inflammation, etc. This review article focuses on the transmission
of α-synuclein and the mechanisms involved in the link between
the gut and the brain in Parkinson’s disease. Also, this review
explores the various pathways involved in Parkinson and current therapeutic
approaches for the improvement of Parkinson’s disease.